TECNIFAR-INDÚSTRIA TÉCNICA FARMACÊUTICA, S.A;TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, SA
发明人:
Miguel Ångelo DA COSTA GARCIA,Carlos Jorge SOUSA DE SÃO JOSÉ,Clara Isabel RODRIGUES LEANDRO,Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva,Ana Raquel MARTINS BARBOSA
申请号：
US15216875
公开号：
US20160317590A1
申请日:
2016.07.22
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophage F387/08, F391/08, F394/08, F488/08, F510/08, F44/10, and F125/10, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophage and/or isolated polypeptides, as well as to methods for the treatment and prevention of bacterial infections using same, either alone or in combination with other antibacterial therapies, e.g., antibiotics and/or other phage therapies.
